Articles tagged with “venture-capital”

Analyze the 2026 biotech capital outlook, detailing Blackstone's record $6.3B Life Sciences Fund VI, VC funding trends, biopharma M&A, and market recovery.

Explore the Boston-Cambridge biotech ecosystem in 2026. This guide covers top companies like Biogen, Vertex & Moderna, venture funding trends, federal policy impacts, and Massachusetts' drug development pipeline.

An educational analysis of AI biotech funding in 2025. Explore venture capital investment trends, funding data, and key deals in AI for drug discovery.

An in-depth analysis of 1,000+ medical device companies in the SF Bay Area, covering the medtech ecosystem, key players like Intuitive Surgical ($10B+ revenue), Penumbra ($14.5B acquisition), and CeriBell's IPO, plus VC funding and market trends through 2026.

An educational analysis of California's AB 1415 and SB 351. Learn how these laws impact private equity and VC in healthcare, including OHCA review and new rules

Explore a data-driven comparison of the AI boom and the dot-com bubble. We analyze key metrics like valuations, profitability, and VC funding — updated with 2026 data including NVIDIA's $4.3T market cap, OpenAI's $730B valuation, and $258.7B in AI VC funding.

An in-depth analysis of the biotech ecosystem in the San Francisco Bay Area, examining key players, emerging startups, investment trends, and innovation clusters as of January 2026. Updated with latest data on 23andMe bankruptcy, major acquisitions, and 2025 layoffs.